Author

Juozas Kupcinskas

CIRCULATING MICROBIOME SINGATURES IN PATIENTS WITH GASTRIC CANCER
CIRCULATING MICROBIOME SINGATURES IN PATIENTS WITH GASTRIC CANCER

Juozas Kupcinskas  et al.

MULTI-LAYER MOLECULAR ANALYSIS IN GASTRIC CANCER PATIENTS’ BLOOD
MULTI-LAYER MOLECULAR ANALYSIS IN GASTRIC CANCER PATIENTS’ BLOOD

Juozas Kupcinskas  et al.

MICRORNA PROFILING ON THE LEVELS OF COLON TISSUE AND EPITHELIAL CELL-POPULATIONS IN PATIENTS WITH ACTIVE AND INACTIVE ULCERATIVE COLITIS
MICRORNA PROFILING ON THE LEVELS OF COLON TISSUE AND EPITHELIAL CELL-POPULATIONS IN PATIENTS WITH ACTIVE AND INACTIVE ULCERATIVE COLITIS

Juozas Kupcinskas  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Juozas Kupcinskas  et al.

THE DISEASE COURSE OF MICROSCOPIC COLITIS – A 5-YEAR PROSPECTIVE EUROPEAN INCIDENCE COHORT (PRO-MC)
THE DISEASE COURSE OF MICROSCOPIC COLITIS – A 5-YEAR PROSPECTIVE EUROPEAN INCIDENCE COHORT (PRO-MC)

Juozas Kupcinskas  et al.

LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1
LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1

Juozas Kupcinskas  et al.

LONG NON-CODING RNA POLYMORPHISMS AND RISK OF GASTRIC CANCER AND ATROPHIC GASTRITIS
LONG NON-CODING RNA POLYMORPHISMS AND RISK OF GASTRIC CANCER AND ATROPHIC GASTRITIS

Juozas Kupcinskas  et al.

GASTRIC CANCER MUCOSAL MICROBIOME IS ASSOCIATED WITH PROGNOSIS OF GASTRIC CANCER PATIENTS
GASTRIC CANCER MUCOSAL MICROBIOME IS ASSOCIATED WITH PROGNOSIS OF GASTRIC CANCER PATIENTS

Juozas Kupcinskas  et al.

EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Juozas Kupcinskas  et al.

MICROSCOPIC COLITIS NO MORE: HLA ASSOCIATION DISCRIMINATES COLLAGENOUS FROM LYMPHOCYTIC COLITIS
MICROSCOPIC COLITIS NO MORE: HLA ASSOCIATION DISCRIMINATES COLLAGENOUS FROM LYMPHOCYTIC COLITIS

Juozas Kupcinskas  et al.

TIME TRENDS AND EFFECTIVENESS OF BISMUTH TREATMENT FOR HELICOBACTER PYLORI INFECTION: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG) DURING 2013-2021
TIME TRENDS AND EFFECTIVENESS OF BISMUTH TREATMENT FOR HELICOBACTER PYLORI INFECTION: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG) DURING 2013-2021

Juozas Kupcinskas  et al.

EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

Juozas Kupcinskas  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Juozas Kupcinskas  et al.

PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Juozas Kupcinskas  et al.

IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Juozas Kupcinskas  et al.

THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Juozas Kupcinskas  et al.

BIOPSY SAMPLING IN UPPER GASTROINTESTINAL ENDOSCOPY - A SURVEY FROM TEN TERTIARY REFERRAL CENTRES ACROSS EUROPE
BIOPSY SAMPLING IN UPPER GASTROINTESTINAL ENDOSCOPY - A SURVEY FROM TEN TERTIARY REFERRAL CENTRES ACROSS EUROPE

Juozas Kupcinskas  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Juozas Kupcinskas  et al.

FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)
FIRST-LINE EMPIRICAL H. PYLORI ERADICATION THERAPY IN EUROPE: RESULTS FROM 30,000 CASES OF THE EUROPEAN REGISTRY ON H. PYLORIMANAGEMENT (HP-EUREG)

Juozas Kupcinskas  et al.

DISEASE COURSE OF CROHN’S DISEASE DURING THE FIRST TEN YEARS FOLLOWING DIAGNOSIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE EPI-IBD COHORT
DISEASE COURSE OF CROHN’S DISEASE DURING THE FIRST TEN YEARS FOLLOWING DIAGNOSIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE EPI-IBD COHORT

Juozas Kupcinskas  et al.

Item 21 - 40 / 47
1
2
3